Mode
Text Size
Log in / Sign up

Can taking cannabinoids help reduce agitation in severe dementia cases?

limited confidence  ·  Last reviewed May 10, 2026

Agitation is a common and distressing symptom in severe dementia. Standard treatments like antipsychotic drugs carry serious risks, including increased mortality 1. Cannabinoids have been studied as a possible alternative. The short answer is that cannabinoids may help reduce agitation, but they also increase the risk of sedation, and the evidence is not yet strong enough to recommend them routinely.

What the research says

A 2025 systematic review and meta-analysis examined the use of cannabinoids for neuropsychiatric symptoms in dementia, including agitation 5. The review found that cannabinoids reduced agitation in people with severe dementia, but they also significantly increased the risk of sedation compared to placebo 5. The authors noted that the quality of evidence was limited due to small sample sizes and short study durations 5. Importantly, the review did not find a significant effect on other symptoms like anxiety or depression 5. This suggests that while cannabinoids might be an option for agitation, the benefits must be weighed against the risk of sedation. Other sources confirm that managing agitation in dementia is challenging. Antipsychotics, often used off-label, are associated with a 32% increased risk of death 1. Non-pharmacological approaches are recommended first, but when they fail, medications may be considered 14. The eDEM-CONNECTONTO ontology highlights the complexity of agitation and the need for tailored interventions 4.

What to ask your doctor

  • What are the potential benefits and risks of using cannabinoids for my relative's agitation?
  • How does the risk of sedation from cannabinoids compare to the risks of other medications like antipsychotics?
  • Are there any ongoing clinical trials for cannabinoids in dementia that we could consider?
  • What non-drug strategies have been tried, and could we explore those further before considering cannabinoids?
  • If we try cannabinoids, how should we monitor for side effects like sedation or falls?

This question is drawn from common patient questions about this topic and answered using cited medical research. We do not provide individualized advice.